Reply to: Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature

dc.date.accessioned	2020-10-21T06:45:55Z
dc.date.available	2020-10-21T06:45:55Z
dc.date.issued	2017
dc.date.issued	2016/10/01
dc.identifier.citation	Solak Y.,,.J Dermatolog Treat. 2017 May;28(3):280. doi: 10.1080/09546634.2016.1215404. Epub 2016 Aug 10.
dc.identifier.uri	http://doi.org/10.1080/09546634.2016.1215404
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71739
dc.description	PMID = 27687138
dc.relation.isversionof	10.1080/09546634.2016.1215404
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Reply to: Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature
dc.type	article
dc.relation.journal	J Dermatolog Treat
dc.identifier.doi	10.1080/09546634.2016.1215404
dc.contributor.author	Solak B
dc.contributor.author	Solak Y.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi